Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urease accessory protein G (UreG) is a small GTPase and metallochaperone that plays a vital role in the maturation of urease, a nickel-dependent enzyme found in various bacteria, fungi, and plants [1, 7]. It functions by coupling the energy from GTP hydrolysis to the insertion of nickel ions into the apo-urease active site, a process requiring a complex assembly with other accessory proteins such as UreD (or UreH), UreF, and UreE [10, 12]. In pathogenic bacteria like Helicobacter pylori, urease activity is essential for survival in the acidic environment of the human stomach, as it produces ammonia to neutralize gastric acid [1, 12]. This colonization leads to significant clinical conditions, including chronic gastritis, peptic ulcers, and an increased risk of gastric cancer [1, 6]. UreG has emerged as a novel therapeutic target for antimicrobial development because direct inhibition of the urease enzyme is often hindered by its deeply buried active site and high substrate specificity [1, 6]. Clinically used bismuth-based drugs, such as colloidal bismuth subcitrate, have been shown to exert their effects by binding to UreG and inhibiting its GTPase activity, thereby preventing the formation of functional urease [1, 2]. Targeting UreG offers a strategic advantage in overcoming antibiotic resistance and improving the efficacy of treatments for urease-associated infections in both the gastrointestinal and urinary tracts [4, 6].
Inhibition of GTPase activity, disruption of urease maturation, and prevention of nickel insertion into the urease active site.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urease accessory protein G (UreG) (UreG).